Prognosis

Swiss Firm Could Make Russian Vaccine as Early as Third Quarter

Adienne Pharma head Di Naro speaks in Bloomberg interview
No decision on where vaccine will be distributed, Di Naro says

WATCH: Antonio Francesco Di Naro, Adienne Pharma CEO and Founder, says deciding to produce the Sputnik V Covid-19 vaccine in Italy ''is not a propaganda tool." (Source: Bloomberg)

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Daniele Lepido, John Follain, and Flavia Rotondi

March 10, 2021 at 8:16 AM UTC

This article is for subscribers only.

The first European company to reach a deal to produce Russia’s Covid-19 vaccine said it could start manufacturing as early as the third quarter, and rejected charges it was part of a propaganda effort as “absurd.”

Antonio Francesco Di Naro, founder and president of Adienne Pharma & Biotech SA, said Wednesday that his company had been selected to make the Sputnik V vaccine following an approach from Russia.